Citadel Advisors
DRTS icon

Citadel Advisors’s Alpha Tau Medical DRTS Stock Holding History

Citadel Advisors’s Portfolio DRTS Stock Details DRTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$774K Buy
61,559
+26,164
+74% +$238K ﹤0.01% 8832
2026
Q1 		$250K Buy
+35,395
New +$250K ﹤0.01% 10906
2025
Q4 		– Sell
-60,600
Closed -$255K – 12917
2025
Q3 		$273K Sell
60,600
-5,879
-9% -$20K ﹤0.01% 10580
2025
Q2 		$207K Buy
66,479
+6,631
+11% +$18.7K ﹤0.01% 10602
2025
Q1 		$150K Buy
+59,848
New +$188K ﹤0.01% 10870
2024
Q4 		– Sell
-16,301
Closed -$38.8K – 14689
2024
Q3 		$38.8K Buy
+16,301
New +$36.1K ﹤0.01% 12173
2022
Q2 		– Sell
-15,668
Closed -$185K – 13094
2022
Q1 		$185K Buy
+15,668
New +$184K ﹤0.01% 11626

Other funds holding DRTS

GIA
Gem Investment Advisors Teaneck, New Jersey $163M AUM
HighTower Advisors
HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
AF
Aquamarine Financial George Town $1.81B AUM 38.21% 1-Year Est. Return
PC
Pier Capital Stamford, Connecticut $755M AUM 94.38% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
AC
Apella Capital West Hartford, Connecticut $7.08B AUM 17.38% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Polen Capital Management
Polen Capital Management Boca Raton, Florida $11.6B AUM 8.03% 1-Year Est. Return
Focus Partners Wealth
Focus Partners Wealth Boston, Massachusetts $97.6B AUM 29.43% 1-Year Est. Return

Citadel Advisors's DRTS Position: Q2 2026 in Review

Citadel Advisors increased its Alpha Tau Medical (DRTS) stake by 74% in Q2 2026, buying an estimated $238K and bringing the position to 61,559 shares worth $774K. The position accounts for ﹤0.01% of the portfolio, ranked #8832.

Citadel Advisors first reported a position in DRTS in Q1 2022 and has held it in 7 quarters since. 74 funds tracked by Wall St. Rank hold DRTS as of Q2 2026.

  • Citadel Advisors held 61,559 shares of Alpha Tau Medical worth $774K as of Q2 2026.
  • Citadel Advisors bought 26,164 Alpha Tau Medical shares in Q2 2026, an estimated $238K.
  • Alpha Tau Medical made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #8832 holding.
  • Citadel Advisors first reported a position in Alpha Tau Medical in Q1 2022 and has held it in 7 quarters since.
  • 74 funds tracked by Wall St. Rank held Alpha Tau Medical as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.